US Congress Makes Another Push for Drug Pricing Regulation

July 15th, 2022|Categories: Featured, Industry News|Tags: , , , , |

With tough odds in the upcoming midterm elections in mind, Democrats in the US Senate are making another push for drug pricing regulation. The latest attempt would limit the out-of-pocket drug costs to $2,000 and let Medicare negotiate drug prices. The proposal would also let the Department of Health and Human Services (HHS) select a small set of drugs for price negotiation, beginning with 10 in 2026 and steadily increasing as time passes.

Go to Top